Announcements

Judy Anderson, VP and CFO of Weyco Group Inc, filed a Form 4 on November 9, 2026, disclosing the sale of 1,263 shares of common stock on November 6, 2026, at a price of $60.12 per share.

Michael A. Pisetsky, SVP of Operations and Administration and Chief Legal Officer of SI-BONE, Inc., filed an amended Form 4/A on November 9, 2026, disclosing transactions in SI-BONE common stock executed on November 4, 2026, pursuant to a Rule 10b5-1 trading plan.

Director William F. Galtney Jr. filed a Form 4 with the SEC on November 9, 2026, reporting the open-market sale of 5,000 common shares of Everest Group, Ltd. (NYSE:EG) on November 6, 2026.

Larry C. Heaton II, Chief Executive Officer and Director of Zomedica Corp., filed a statement of changes in beneficial ownership on November 9, 2026, reporting the acquisition of stock options on November 6, 2026.

A Form 4 filed on November 9, 2026 with the U.S. Securities and Exchange Commission discloses that Ken Rizvi, Senior Vice President and Chief Financial Officer of Qnity Electronics, Inc., acquired 69,438 shares of common stock on November 5, 2026 at a price of …

Medicus Pharma Ltd. filed a Form 425 on November 9, 2026, containing the script from its third-quarter and nine-months-ended September 30, 2026, business update conference call, covering a co-development and license agreement with Pfizer, a proposed SkinJect business combination, and an update on its …

Laurence Denny, Chief Legal Officer of 8X8 INC /DE/, filed a Form 4 on November 9, 2026, disclosing the sale of 10,000 shares of common stock on November 5, 2026, under a pre-established Rule 10b5-1 trading plan.